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Introduction 1
Medicated feed is frequently used for parasite control in wildlife populations, including red grouse 2 (Newborn & Foster 2002) , pheasants (Draycott et al., 2006) and bighorn sheep (Miller et al., 2000; 3 Schmidt et al., 1979) . Because these animals self-administer, drug uptake may vary among 4 individuals and over time, for example due to differential access to feed. Assessment of drug uptake 5 (and therefore efficacy), which is already difficult in self-administering populations, is hindered 6 further by this variation. To aid parasite management in these situations, a reliable method to 7 quantify drug uptake is required. 8 9 One such approach is the quantification of drug residues in the tissues of harvested animals. Here 10 we develop a quantification method for red grouse (Lagopus lagopus scoticus), an economically 11 important game bird species endemic to the British Isles. Red grouse exhibit regular population 12 collapses owing in part to high burdens of the parasitic nematode Trichostrongylus tenuis (Hudson 13 et al., 1998) . Control of these intestinal parasites helps reduce the frequency and severity of 14 population crashes (Hudson et al., 1998) . The most widespread technique for controlling T. tenuis 15 in red grouse has been the provision of quartz grit, which grouse consume to aid digestion, coated 16 with the anthelmintic drug fenbendazole (FBZ) . Recently, the use of grit coated with flubendazole 17 (FLUB), has also become widespread. Medicated grit piles are distributed on red grouse habitat in 18
December and replenished in early March (Newborn and Foster, 2002) . No medicated grit is 19 distributed after the end of March (Intervet UK Ltd, Panacur Data Sheet), resulting in a minimal 20 withdrawal period of 19 weeks to prevent FBZ residues (i.e. FBZ and its metabolites) from entering 21 food products when grouse are harvested for human consumption from 12 August to 16 December. 22
Treatment with FBZ-medicated grit has been shown to reduce average worm burdens by 34% 23 (Newborn and Foster, 2002) . 24 25 FBZ is a member of the benzimidazole (BZ) group of anthelmintics which provides broad-spectrum 26 efficacy against endoparasites and is widely used in domestic animals and humans (McKellar and 27 Scott, 1990) . Methods have been developed for the quantification of FBZ residues in liver, muscle 28 and plasma from a range of domestic animals, including cattle, sheep and fish, using High 29
Performance Liquid Chromatography (HPLC) or Liquid Chromatography-Mass Spectrometry 30 (LC-MS) . Here we present a method to quantify FBZ residues in red grouse 31 livers using HPLC coupled to an ion trap tandem mass spectrometer (HPLC-MS-MS). We 32 measured simultaneously FBZ and two of its metabolites, fenbendazole sulphone (FBZSO 2 ) and 33 oxfendazole (OFZ), plus an internal standard mebendazole (MBZ). Liver tissue was selected for 34 analysis because it contains the highest total residue levels and is the tissue from which residues 35 deplete most slowly (European Medicines Agency, 2004) . 36
37
The aims of this study were threefold: (1) to develop a simple and reliable method to quantify FBZ 38 residues in grouse livers; (2) to assess variation in FBZ dosage among birds during treatment 39 periods (December to March); and (3) to measure FBZ residue levels in samples from the shooting 40 season (August 12 to December 10) in order to quantify residues entering food products. 41
42

Materials and methods 43
We obtained livers from 14 male red grouse aged at least 1 year from three grouse moors in the 44 north of England, UK during August 2002 and March and August 2003 (Table 1) after drug treatment had ceased. Males more than one year old, and therefore likely to have had 51 access to medicated grit treatments earlier in the year, were selected at random from the grouse 52 harvested that day from each site. The remaining 10 samples were collected from dead birds outside 53 the shooting season in March 2003. These samples were taken opportunistically, and we have no 54 information on self-medication frequency, dosage or proximity to medicated grit piles. We also 55 cannot assume that sampling was representative. Nevertheless, as medicated grit piles were 56 available to the grouse during this period, these samples were considered more likely to contain 57 detectable residues than those collected in August. After collection, liver samples were frozen on 58 dry ice (-78.5 °C) and transported to storage at -70 °C. Medicated grit was also collected from a grit 59 pile in March 2003 and stored at -70 °C. 60
61
Frozen liver samples were thawed and 300 mg subsamples were removed to 50 mL centrifuge 62 tubes. To monitor variation introduced by the extraction procedure, two sub-samples were extracted 63 from each liver and each was analysed separately. Control (drug negative) livers from the untreated 64 site Y NEG were selected for spiking with drug standards after we had checked that no detectable 65 drug residues were present. Sample and control liver samples were fortified with 100 ng of the 66 internal standard mebendazole (MBZ) to allow standardisation of recovery rates across HPLC-MS-67 MS assays. Mean (±SD) recovery of the internal standard was 78 (±18) %. Control liver samples 68 were also fortified with FBZ at a range of concentrations to allow validation of the method. The 69 quantities added were 0, 0.05, 0.5, 5 and 50 ng, equivalent to 0, 0.167, 1.67, 16.7 and 167 µg kg -1 of 70 liver. 71
72
The residues to be quantified were FBZ and its metabolites oxfendazole (OFZ) and fenbendazole 73 sulphone (FBZSO 2 ) (Supplementary Figure 1) . The presence of OFZ and FBZSO 2 are indicative of 74 FBZ intake . Among the eight birds where residues were detected -indicating exposure to FBZ -there was a 99 strong tendency for the concentrations of both of the FBZ metabolites, OFZ and FBZSO 2 , to be 100 higher than FBZ itself. This result agrees with data from sheep liver, where FBZ depleted ten times 101 more quickly than OFZ over an 8 day period (Blanchflower et al., 1994) . Levels of the three 102 residues tended to covary. Log concentrations of OFZ and FBZSO 2 were strongly positively 103 correlated among the eight livers (r = 0.96, n = 8). Log concentrations of OFZ and FBZSO 2 were 104 also correlated with FBZ but less strongly (FBZ-OFZ r = 0.86, n = 4; FBZ-FBZSO 2 r = 0.78, n =4). From site Y FBZ , the samples collected during the shooting season (Y FBZ 1-Y FBZ 2) tested positive 106 for FBZ metabolites (Table 2) , whereas the samples collected during the period of medicated grit 107 treatment (Spring 2003) showed no detectable levels of FBZ or its metabolites. FBZ residues were 108 generally at a higher level in March (during the treatment period) than in August (Table 2) , 109 although these differences were significant only for FBZ (P = 0.02, Wilcoxon rank sum test). 110
111
No FBZ was found in the medicated grit sample, although its metabolites OFZ and FBZSO 2 were 112 detected at high levels relative to those observed in the liver samples ( Table 2 ). The peak areas for 113 these metabolites were above the LOQ, considerably so in the case of the active metabolite OFZ, 114
and therefore the amount of active anthelmintic remaining of the 1000 µg kg -1 FBZ in fresh grit 115
could not be quantified. 116 117 Discussion 118
When parasite control in free-living animals involves medicated grit or feed instead of direct drug 119 application, managers need simple and efficient tools to monitor temporal and spatial variation in 120 drug uptake. Our method for detecting the anthelmintic fenbendazole and its metabolites in liver 121 tissue of game birds provides such a tool. The sensitivity of the method is demonstrated by the low 122 LOD and by the detection of benzimidazole residues four months after the withdrawal of medicated 123 grit piles. The lack of false positives among negative controls and samples from the untreated moor 124 indicate high specificity. All but one of the pairs of replicate samples agreed in sensing the presence 125 or absence of BZ residues, indicating that the technique is reliable but that running duplicate 126 samples is advisable. The simplicity and speed of the method would allow it to be offered to estate 127 managers at a cost that is low compared to the cost of treatment. 128 129 Our method could also aid the prevention of the development of anthelmintic resistance. Since the 130 pace and extent of anthelmintic resistance evolution is greatly affected by variation in drug dosage 131 (Smith et al., 1999) , managers should consider using the technique presented here to monitor 132 individual variation in drug uptake to identify conditions and methods that delay the onset of drug 133 resistance among the parasites for as long as possible. Our method may also be applicable to other 134 game bird species such as pheasants (Draycott et al., 2006) , and with the necessary modifications, 135 to free-living mammals such as bighorn sheep (Miller et al., 2000; Schmidt et al., 1979) where 136 medicated feeds are used and where drug uptake may vary greatly among individuals. 137
138
Our study was based on samples collected from wild grouse for which we had no information on 139 proximity to medicated grit piles, dosing frequency, length of time since the last dose, or how 140 representative samples were of the grouse moor populations. Thus, the livers we analysed may 141 therefore have been at different stages and levels of fortification. Despite these caveats, we found 142 striking differences among birds in levels of the active anthelmintics FBZ and OFZ during the 143 treatment period. FBZ was detected in only four of the seven samples taken from treated sitesduring the treatment period (Table 2) . Indeed, one of the treated sites (Y FBZ ) exhibited no 145 measurable FBZ residues from any of the three birds sampled during the treatment period. These 146 differences in residue level may reflect variation in the time since the last ingestion of medicated 147 grit. However it is also possible that these differences reflect long term variation among birds in 148 FBZ uptake caused by differential access to medicated grit piles in conjunction with territorial 149 behaviour (Mougeot et al., 2003) . Either way, our results suggest that there is substantial room for 150 improvement to enable more birds to receive adequate FBZ dosage to control T. tenuis parasites. are established for anthelmintic residues in products for human consumption from most livestock 155 species and these tend to be in the order of 10 µg kg -1 for milk and 500 µg kg -1 for liver in bovine, 156 ovine, porcine and equine species (European Commission, 1990 ). The levels measured in our study 157 are well below these limits, and therefore our data provide no evidence that the 19-week withdrawal 158 period is insufficient to prevent human consumption of harmful levels of anthelmintic residues. 159 160 161 Acknowledgments -we thank Intervet International for donating fenbendazole sulphone. We are 162 grateful to D. Newborn, the Game and Wildlife Conservation Trust, UK, and many gamekeepers 163 and estate owners for advice, access to sampling sites and assistance with sampling. We are also 164 grateful to two anonymous reviewers who provided useful comments on an earlier draft of this 165 manuscript. This study was supported by a project grant from The Leverhulme Trust, UK. 
Supplementary methods
Subsamples of 300 mg of each liver were allowed to stand for 30 min before being frozen at -70 ºC prior to freeze-drying for 36-48 hr. On removal samples were homogenised with a mortar and pestle and dry weights were taken. The standard deviation of the dry weights of the samples was 13% of the mean. Methanol (20 mL) was added to the ground tissue and each sample was vortexed for 5 min before centrifugation at 4000 rpm for 20 min at 4 °C in a cooling centrifuge. The supernatant was removed and partitioned with an equal volume of hexane. Partitioning was repeated before the methanol portion was removed to a quick-fit flask and evaporated to dryness using a rotary evaporator. The dried residue was resuspended in 1 mL methanol and vortexed. Samples were centrifuged in a sample concentrator for 1 hr 30 min and the pellet resuspended in 100 µl methanol.
The extractions were centrifuged for a further 30 min at 13000 rpm to remove any remaining impurities. Finally, the purified supernatant was removed and used for HPLC-MS-MS analysis.
Medicated grit samples were extracted in the same way as livers, with the exception that 1 g of grit was used.
Samples were analysed on a Surveyor HPLC system comprising of a HPLC pump, diode array absorbance detector, scanning from 250 to 700 nm and an autosampler cooled to 4°C. HPLC separation was carried out using a 4 µm, 250 × 2.0 mm i. were prepared at a concentration of 1 mg mL -1 in dimethyl sulfoxide + methanol (9/1, v/v). The internal standard was chosen due to its structural similarities to the compound under investigation and was used to control for extraction, HPLC and ionization variability. These solutions were stored at 5 ºC and showed no significant changes after one month, when they were replaced by fresh solutions. Working standard solutions were prepared at concentrations ranging from 5-50,000 ng mL -1 by dilution with dimethyl sulfoxide + methanol (9/1, v/v). A standard solution, 100 ng mL -1 was used for tuning the mass spectrometer. Linear calibration curves were generated by plotting ln(peak area) against ln(working standard solution concentration). the MS-MS spectrum was used as additional proof of compound identity and peak purity. The use of Selected Reaction Monitoring using an ion trap mass spectrometer allows confirmation of the peak under investigation, by providing the full fragmentation spectra of the parent ion, without a loss of sensitivity. Only the major fragment ion formed from each parent was used in quantification.
The limit of detection (LOD) was determined at a signal to noise ratio of 3, as reported by the Xcalibur peak integration software and quantification was carried out on peaks that had a signal to noise ratio greater than 9. No false positive peaks were detected for any of the four compounds under investigation during the course of the study. Tissue drug residue concentration in µg kg -1 (ppb) was calculated from sample drug concentrations (estimated from the calibration curve), sample solution volume and sample weight. Mean (±SD) recovery of the internal standard was 78 (±18) %; where recovery was less than 100%, residue concentration was adjusted by dividing by the recovery fraction.
The extraction method used in this analysis is much quicker and simpler than any reported for similar compounds . Although the lack of clean up stages could result in more contaminants in the extract, no interfering peaks or false positives were seen in the analysis.
The sensitivity and selectivity of the analysis allowed sample weights to be reduced to only 300 mg of liver. The low variation in the dry weights of these samples suggests that 300 mg samples can be weighed with a sufficient degree of accuracy for detection and quantification. However, it is likely that the accuracy of quantification would be further improved by increasing the sample weight. 
